Enlivex Ltd. (ENLV) Financial Statements
Free cash flow over the same period: -$15.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ENLVEnlivex Ltd.Follow ENLV — free
—
Price chart with a free account
- Market cap
- 2.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | — | |
| Operating income | -0.01 | -0.02 | -0.02 | -0.00 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 | |
| Pre-tax income | -0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | — | -0.03 | -0.02 | 1.62 | 4.16 | |
| Income tax | — | 0.00 | 0.00 | 0.00 | -0.00 | — | — | — | — | — | — | 0.38 | — | |
| Net income | -0.01 | -0.02 | -0.02 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.03 | -0.03 | -0.02 | 1.24 | 3.19 | |
| Diluted EPS ($) | -0.57 | -1.08 | -40.13 | -0.94 | -1.40 | -1.11 | -0.90 | — | -1.69 | -1.56 | -0.73 | 25.48 | 177.61 | |
| Diluted shares (bn) | — | — | — | — | — | — | — | — | 0.018 | 0.019 | 0.021 | 0.048 | — |
USD billions · SEC XBRL
Enlivex Ltd. — questions
- What is Enlivex Ltd.'s net income?
- $3.2B over the twelve months to 2026-06-30.
- What is Enlivex Ltd.'s free cash flow?
- -$15.6M over the twelve months to 2026-06-30.
- What are Enlivex Ltd.'s diluted earnings per share?
- $177.61 over the twelve months to 2026-06-30.
Every figure on this page comes from Enlivex Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.